Skip to main content
OpenTrials

Clinical trial condition

Nocturia

Explore clinical trials studying Nocturia. Study availability and eligibility vary by location and protocol.

104 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Nocturia trial results

Completed

A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

NCT05597020

Conditions
Dyssomnias, Insomnia Disorder, Lower Urinary Tract Symptoms, +9 more
Locations
  • Quantum Clinical Trials Miami Beach, Florida, United States
  • Clinical Research Center of Florida Pompano Beach, Florida, United States
  • Encore Medical Research of Weston Weston, Florida, United States
  • Ochsner LSU Health Shreveport-Regional Urology Shreveport, Louisiana, United States
View all 16 locations
View Trial Details
Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

NCT01972841

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +15 more
Locations
  • Site US10049 Coastal Clinical Research, Inc. Mobile, Alabama, United States
  • Site US10112 TFI, LLC Mobile, Alabama, United States
  • Site US10104 Clinical Research Advantage, Inc. Chandler, Arizona, United States
  • Site US10021 Beach Clinical Studies Phoenix, Arizona, United States
View all 435 locations
View Trial Details
Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

NCT02045862

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +15 more
Locations
  • Site US10049 Mobile, Alabama, United States
  • Site US10112 Mobile, Alabama, United States
  • Site US10104 Chandler, Arizona, United States
  • Site US10021 Phoenix, Arizona, United States
View all 251 locations
View Trial Details
Completed

Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +21 more
Locations
  • Birmingham VA Medical Center, Birmingham, AL Birmingham, Alabama, United States
  • Atlanta VA Medical and Rehab Center, Decatur, GA Decatur, Georgia, United States
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States
  • Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond, Virginia, United States
View Trial Details

Related conditions